Operational Excellence in Regulated Manufacturing
Improvement and compliance are usually presented as a trade-off and usually are not one. The largest waste streams in a regulated plant are rework, investigation, deviation handling and the delay they cause, all of which are symptoms of poor control rather than of excessive control. But an improvement programme that treats procedures as waste will remove the wrong things, and the distinction is not always obvious to someone trained outside the sector.
What an explainer is not
A topic explainer is SPEQ’s synthesis of what a practice involves, cited to the standards that govern it. It does not reproduce their text, and it does not determine which of them apply to your product or process.
[ POSITION IN THE FRAMEWORK ]
7 DIMENSIONS · 22 LINKSImprovement in a regulated plant is constrained by what can be justified: an idea that cannot survive change control is not an improvement, and a programme that routes around change control is a validated state being lost by consent.
06 · QUALITY MATURITY — OPERATIONAL EXCELLENCE IN REGULATED MANUFACTURING, REACTIVE TO ADAPTIVE
Improvement means cost reduction projects. Their interaction with the validated state is discovered during implementation.
A programme exists with trained practitioners and a project pipeline, and change control is experienced as the obstacle it keeps running into.
Improvement work starts from process understanding, so a proposed change arrives with the data that justifies it and passes change control on its evidence.
The improvement and quality systems share their data, so variability reduction and deviation reduction are the same programme rather than two.
Capability improves because the process is understood well enough to be changed confidently, and the change record is the improvement evidence rather than an obstacle to it.
SPEQ’s shared five-stage progression, labelled synthesis — not the FDA QMM rating scale. Where does your organization sit? Score your quality system →
07 · REGULATORY & EVIDENCE
GOVERNING STANDARDS · 5
Derived from the 5 standards SPEQ maps to this subject, across 4 regulatory bodies: FDA, ICH, ISO, PIC/S.
RECORDS & OBJECTIVE EVIDENCE
- Improvement projects with their change-control records, where a change was made
- The process understanding or data supporting each proposed change
- Capability and variability data before and after implemented changes
- The link between improvement priorities and deviation, complaint or yield data
- Effectiveness verification for changes made as improvements
COMMON INSPECTION FINDINGS
- Process changes implemented as improvements without change control
- An improvement programme whose priorities bear no relation to where the problems are
- Claimed benefits with no before-and-after data to support them
- Standardisation rolled across sites without site-specific assessment
- Improvement and quality functions holding different views of the same process
Where the waste actually is
Value-stream mapping in a regulated plant reliably finds the same picture: the process step takes hours and the batch takes weeks, with most of the elapsed time spent waiting — for testing, for review, for a deviation to close, for a disposition decision. Direct process efficiency is rarely the constraint, and the improvement effort that targets it is optimising the smallest term.
The large opportunities sit in the quality system rather than in the plant: cycle time of deviation investigation, batch record review and error rate, laboratory turnaround, and the rework generated by unclear procedures. These are not compliance overheads to be reduced; they are failures of control whose elimination improves compliance and throughput together, which is why the trade-off framing is usually wrong.
What must not be removed
A lean programme run by people without regulatory background will find obvious targets that are not: the second-person verification that looks like duplication, the record that nobody reads, the sampling that always passes. Some of these genuinely are waste. Others are controls whose value is that they have not yet failed, and removing them converts a rare event into a plausible one.
The workable discipline is a regulatory-impact assessment as a required step in any improvement affecting a GxP process, asking what the step protects against and what would detect that failure if the step were removed. That is not bureaucracy added to improvement — it is the analysis that distinguishes a genuine redundancy from a control, and it usually takes an hour.
ICH Q10 already asks for this
Continual improvement of process performance and product quality is one of the four objectives of the pharmaceutical quality system under ICH Q10, alongside achieving product realisation, establishing a state of control, and facilitating continual improvement. The framework explicitly anticipates change management, knowledge management and management review as the enablers.
So an operational-excellence programme in a regulated site is not an initiative bolted alongside the quality system; it is an obligation the quality system already carries and most organisations under-deliver. Framing it that way also solves a political problem — improvement resourced as a business programme competes with quality, while improvement framed as a Q10 objective is quality.
SPEQ interpretation — measure the cost of poor quality, not the savings
Improvement programmes report savings, and savings are contestable. A more durable measure is the cost of poor quality: the money the organisation is already spending on rework, investigation, scrap, retesting, delayed release and complaint handling. That number is large, it is derived from data the organisation already holds, and it does not require anyone to agree that a projected saving is real.
It also reframes the argument. A plant told to cut cost hears a threat to its controls; a plant shown what its deviation backlog costs per month sees an internal problem it wants to fix. The measurement is the intervention, more often than the improvement project that follows it.
FREQUENTLY ASKED
Do improvement and compliance genuinely trade off?
Usually not. The largest waste streams in a regulated plant — rework, investigation, deviation handling and the delay they cause — are symptoms of poor control, so eliminating them improves compliance and throughput together. The trade-off appears only when a programme targets controls rather than failures.
How do you tell a redundant step from a control?
Ask what the step protects against and what would detect that failure if the step were removed. A regulatory-impact assessment as a required gate on any improvement touching a GxP process takes about an hour and is what separates genuine duplication from a control whose value is that it has not yet failed.
Where should improvement effort be aimed in a regulated plant?
At elapsed time rather than process time. The process step takes hours and the batch takes weeks, with most of that spent waiting on testing, review, deviation closure and disposition. Deviation investigation cycle time, batch record review error rate and laboratory turnaround are usually larger opportunities than line efficiency.
Is operational excellence separate from the quality system?
No. Continual improvement of process performance and product quality is one of ICH Q10’s four objectives, with change management, knowledge management and management review named as enablers. Treating improvement as a separate business programme puts it in competition with quality rather than inside it.